|
US4867973A
(en)
|
1984-08-31 |
1989-09-19 |
Cytogen Corporation |
Antibody-therapeutic agent conjugates
|
|
US5567584A
(en)
|
1988-01-22 |
1996-10-22 |
Zymogenetics, Inc. |
Methods of using biologically active dimerized polypeptide fusions to detect PDGF
|
|
US6018026A
(en)
|
1988-01-22 |
2000-01-25 |
Zymogenetics, Inc. |
Biologically active dimerized and multimerized polypeptide fusions
|
|
NZ235148A
(en)
|
1989-09-05 |
1991-12-23 |
Immunex Corp |
Tumour necrosis factor receptor protein and dna sequences
|
|
IE922437A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Recombinant antibodies for human therapy
|
|
SE9201073D0
(sv)
*
|
1992-04-03 |
1992-04-03 |
Kabi Pharmacia Ab |
Protein formulation
|
|
PT672141E
(pt)
|
1992-10-23 |
2003-09-30 |
Immunex Corp |
Metodos de preparacao de proteinas oligomericas soluveis
|
|
EP0808163B1
(en)
|
1995-01-18 |
2003-07-23 |
Alteon, Inc. |
Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
|
|
NO315930B1
(no)
|
1995-01-18 |
2003-11-17 |
Picower Inst For Medical Res T |
Anvendelse av tiazoliumforbindelser ved fremstilling av farmasöytiske preparater, preparater som inneholder forbindelsene, samt nyetiazoliumforbindelser
|
|
US5656261A
(en)
|
1995-01-18 |
1997-08-12 |
The Picower Institute For Medical Research |
Preventing and reversing advanced glycosylation endproducts
|
|
WO1996031537A1
(en)
|
1995-04-05 |
1996-10-10 |
The Picower Institute For Medical Research |
Agents for binding to advanced glycosylation endproducts, and methods of their use
|
|
US5747035A
(en)
|
1995-04-14 |
1998-05-05 |
Genentech, Inc. |
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
WO1997026913A1
(en)
|
1996-01-26 |
1997-07-31 |
The Trustees Of Columbia University In The City Of New York |
A POLYPEPTIDE FROM LUNG EXTRACT WHICH BINDS AMYLOID-β PEPTIDE
|
|
US5864018A
(en)
|
1996-04-16 |
1999-01-26 |
Schering Aktiengesellschaft |
Antibodies to advanced glycosylation end-product receptor polypeptides and uses therefor
|
|
WO1997039121A1
(en)
|
1996-04-16 |
1997-10-23 |
Schering Aktiengesellschaft |
Advanced glycosylation end-product receptor peptides and uses therefor
|
|
US6790443B2
(en)
|
1996-11-22 |
2004-09-14 |
The Trustees Of Columbia University In The City Of New York |
Method for treating symptoms of diabetes
|
|
US6555651B2
(en)
|
1997-10-09 |
2003-04-29 |
The Trustees Of Columbia University In The City Of New York |
Ligand binding site of rage and uses thereof
|
|
US7258857B2
(en)
|
1996-11-22 |
2007-08-21 |
The Trustees Of Columbia University In The City Of New York |
Rage-related methods for treating inflammation
|
|
US7081241B1
(en)
|
1998-10-06 |
2006-07-25 |
The Trustees Of Columbia University In The City Of New York |
Extracellular rage binding protein (EN-RAGE) and uses thereof
|
|
EP1007048A4
(en)
|
1997-03-11 |
2004-09-22 |
Gen Hospital Corp |
IDENTIFICATION OF MEANS FOR TREATING ALZHEIMERISCHEN DISEASE
|
|
US7101838B2
(en)
|
1997-08-05 |
2006-09-05 |
The Trustees Of Columbia University In The City Of New York |
Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
|
|
MY131805A
(en)
*
|
1997-09-18 |
2007-09-28 |
Biogen Idec Inc |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis.
|
|
US6380165B1
(en)
|
1997-09-19 |
2002-04-30 |
The Picower Institute For Medical Research |
Immunological advanced glycation endproduct crosslink
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US6323218B1
(en)
|
1998-03-11 |
2001-11-27 |
The General Hospital Corporation |
Agents for use in the treatment of Alzheimer's disease
|
|
US6465422B1
(en)
|
1998-04-17 |
2002-10-15 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting tumor invasion or spreading in a subject
|
|
WO2000018970A1
(fr)
|
1998-09-29 |
2000-04-06 |
Asahi Kasei Kabushiki Kaisha |
Procede de commande de liberation de granules
|
|
US6753150B2
(en)
|
1998-10-05 |
2004-06-22 |
The Trustees Of Columbia University In The City Of New York |
Method for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
|
|
KR100731820B1
(ko)
*
|
1998-10-05 |
2007-06-25 |
파멕사 에이/에스 |
치료적 백신화를 위한 새로운 방법
|
|
AU765719B2
(en)
|
1998-10-06 |
2003-09-25 |
Trustees Of Columbia University In The City Of New York, The |
Extracellular novel rage binding protein (EN-RAGE) and uses thereof
|
|
US6197294B1
(en)
|
1998-10-26 |
2001-03-06 |
Neurotech S.A. |
Cell surface molecule-induced macrophage activation
|
|
US6787566B2
(en)
|
1999-04-05 |
2004-09-07 |
City Of Hope |
Breakers of advanced glycation endproducts
|
|
US6589944B1
(en)
|
1999-04-05 |
2003-07-08 |
City Of Hope |
Breakers of advanced glycation endproducts
|
|
US6605642B2
(en)
|
1999-04-05 |
2003-08-12 |
City Of Hope |
Inhibitors of formation of advanced glycation endproducts (AGES)
|
|
US6939545B2
(en)
|
1999-04-28 |
2005-09-06 |
Genetics Institute, Llc |
Composition and method for treating inflammatory disorders
|
|
US6835200B2
(en)
|
1999-06-22 |
2004-12-28 |
Ndo Surgical. Inc. |
Method and devices for tissue reconfiguration
|
|
FR2797402B1
(fr)
|
1999-07-15 |
2004-03-12 |
Biomerieux Stelhys |
Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
|
|
JP2003507013A
(ja)
|
1999-08-13 |
2003-02-25 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク |
βシートフィブリルのＲＡＧＥへの結合を阻害する方法及びその結果
|
|
EP1219639A4
(en)
|
1999-09-08 |
2009-03-25 |
Toray Industries |
CIPO - Patent
|
|
US20050170382A1
(en)
|
1999-10-06 |
2005-08-04 |
The Trustees Of Columbia University In The City Of New York. |
RAGE-related compositions
|
|
IL143936A0
(en)
|
1999-10-21 |
2002-04-21 |
Univ Case Western Reserve |
Gene expression profiling of inflammatory bowel disease
|
|
CA2382165A1
(en)
|
1999-12-08 |
2001-06-14 |
Genset S.A. |
Full-length human cdnas encoding potentially secreted proteins
|
|
JP3920641B2
(ja)
|
2000-04-14 |
2007-05-30 |
ナイアダイン コーポレーション |
タンパク質−後期糖化反応生成物（タンパク質−ａｇｅ）形成の調節因子を同定する方法
|
|
US20010041349A1
(en)
|
2000-04-17 |
2001-11-15 |
Andrew Patron |
Protein expression system arrays and use in biological screening
|
|
US6825164B1
(en)
|
2000-08-14 |
2004-11-30 |
The Trustees Of Columbia University In The City Of New York |
Method to increase cerebral blood flow in amyloid angiopathy
|
|
US6563015B1
(en)
|
2000-08-14 |
2003-05-13 |
The Trustees Of Columbia University In The City Of New York |
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof
|
|
WO2002029091A2
(en)
|
2000-10-02 |
2002-04-11 |
Reddy Us Therapeutics, Inc. |
Methods and compositions for the treatment of inflammatory diseases
|
|
AU2002213192A1
(en)
|
2000-10-13 |
2002-04-22 |
The Trustees Of Columbia University In The City Of New York |
A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
|
|
US20050244849A1
(en)
|
2000-12-15 |
2005-11-03 |
Genetics Institute, Llc |
Screening assays for rheumatoid arthritis
|
|
PL366250A1
(en)
|
2000-12-29 |
2005-01-24 |
Reddy Us Therapeutics, Inc. |
Detection of compounds that modulate inflammatory responses
|
|
PL362324A1
(en)
|
2001-02-19 |
2004-10-18 |
Merck Patent Gmbh |
Artificial fusion proteins with reduced immunogenicity
|
|
JP3837494B2
(ja)
|
2001-03-19 |
2006-10-25 |
国立大学法人金沢大学 |
可溶型ｒａｇｅタンパク質
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
MXPA05001758A
(es)
|
2002-08-16 |
2005-08-19 |
Wyeth Corp |
Composiciones y metodos para el tratamiento de trastornos asociados a receptor para productos finales de glicatacion avanzada (rage).
|
|
US8067371B2
(en)
|
2003-05-09 |
2011-11-29 |
The Trustees Of Columbia University In The City Of New York |
RAGE G82S-related methods and compositions for treating inflammatory disorders
|
|
WO2005021710A2
(en)
|
2003-06-02 |
2005-03-10 |
University Of Miami |
Chimeric molecules and methods of use
|
|
CN1874782A
(zh)
|
2003-09-05 |
2006-12-06 |
纽约市哥伦比亚大学信托人 |
治疗肾小球损伤的rage－相关方法与组合物
|
|
WO2005042032A1
(en)
|
2003-10-31 |
2005-05-12 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating multiple sclerosis
|
|
US20060012414A1
(en)
*
|
2004-07-15 |
2006-01-19 |
Texas Instruments Incorporated |
Circuit and method for generating a polyphase clock signal and system incorporating the same
|
|
WO2006012414A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Novel polyadenylation signal for use in expression vectors
|
|
WO2006012415A2
(en)
*
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Rage protein derivatives
|
|
EP1776459A1
(en)
*
|
2004-08-03 |
2007-04-25 |
Transtech Pharma, Inc. |
Rage fusion proteins and methods of use
|
|
ES2473587T3
(es)
|
2004-08-03 |
2014-07-07 |
Transtech Pharma, Inc. |
Proteínas de fusión de RAGE y métodos de uso
|
|
EP1799700A4
(en)
|
2004-09-27 |
2009-02-11 |
Centocor Inc |
SRAGE MIMETIC BODIES, COMPOSITIONS, PROCESSES AND USES
|
|
US20080207499A1
(en)
|
2005-06-29 |
2008-08-28 |
Gaetano Barile |
Rage-related methods for treating and preventing diabetic retinopathy
|
|
WO2007094926A2
(en)
|
2006-02-09 |
2007-08-23 |
Transtech Pharma, Inc. |
Rage fusion proteins and methods of use
|
|
EA017291B1
(ru)
|
2006-05-05 |
2012-11-30 |
Транстек Фарма, Инк. |
Белки слияния на основе rage, их композиции и способы их применения
|
|
WO2008100470A2
(en)
|
2007-02-15 |
2008-08-21 |
Transtech Pharma, Inc. |
Rage - immunoglobulin fusion proteins
|